Bibliografia 

1. Dupont C, Armant DR, Brenner CA (September 2009). "Epigenetics: definition, mechanisms and clinical perspective". Seminars in Reproductive Medicine. 27 (5): 351–7. doi:10.1055/s-0029-1237423. PMC 2791696. PMID 19711245.
2. Rutherford A (19 July 2015). "Beware the pseudo gene genies". The Guardian.
3. Bird A (May 2007). "Perceptions of epigenetics". Nature. 447 (7143): 396–8. Bibcode:2007Natur.447..396B. doi:10.1038/nature05913. PMID 17522671. S2CID 4357965.
4. Hunter P (1 May 2008). "What genes remember". Prospect Magazine. Archived from the original on 1 May 2008. Retrieved 26 July 2012.
5. Lim, Derek H K e Eamonn R Maher. "Metilazione del DNA: una forma di controllo epigenetico dell'espressione genica." The Obstetrician & Gynecologist, Blackwell Publishing Ltd, 24 gennaio 2011
6. Bocklandt S, Lin W, Sehl ME, Sánchez FJ, Sinsheimer JS, Horvath S, Vilain E. Epigenetic predictor of age. PLoS One. 2011;6(6):e14821.
7. Horvath, S. et al. Accelerated epigenetic aging in Down syndrome. Aging Cell 14, 491–495 (2015).
8. Horvath, S. et al. An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease. Genome Biol 17, 171 (2016).
9. Horvath et al. - 2016 - An epigenetic clock analysis of raceethnicity, se.pdf. 5. Hannum, G. et al. Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging Rates. Molecular Cell 49, 359–367 (2013).
10. Horvath, S. et al. Huntington’s disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels. Aging 8, 1485–1512 (2016).
11. Davis, E. G. et al. Accelerated DNA methylation age in adolescent girls: associations with elevated diurnal cortisol and reduced hippocampal volume. Transl Psychiatry 7, e1223–e1223 (2017).
12. Dozmorov, M. G., Coit, P., Maksimowicz-McKinnon, K. & Sawalha, A. H. Age-associated DNA methylation changes in naive CD4 + T cells suggest an evolving autoimmune epigenotype in aging T cells. Epigenomics 9, 429–445 (2017).
13. Solovev, I., Shaposhnikov, M. & Moskalev, A. Multi-omics approaches to human biological age estimation. Mechanisms of Ageing and Development 185, 111192 (2020).
14. Salameh, Y., Bejaoui, Y. & El Hajj, N. DNA Methylation Biomarkers in Aging and Age-Related Diseases. Front. Genet. 11, 171 (2020).
15. Horvath, S. et al. Obesity accelerates epigenetic aging of human liver. Proceedings of the National Academy of Sciences 111, 15538–15543 (2014).
16. Horvath, S. et al. Decreased epigenetic age of PBMCs from Italian semi-supercentenarians and their offspring. Aging 7, 1159–1170 (2015).
17. Hayano, M. et al. DNA Break-Induced Epigenetic Drift as a Cause of Mammalian Aging. http:// biorxiv.org/lookup/doi/10.1101/808659 (2019) doi:10.1101/808659.
18. Dick, K. J. et al. DNA methylation and body-mass index: a genome-wide analysis. The Lancet 383, 1990–1998 (2014).
19. Geurts, Y. M. et al. Novel associations between blood DNA methylation and body mass index in middle-aged and older adults. Int J Obes 42, 887–896 (2018).
20. Wahl, S. et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature 541, 81–86 (2017).
21. Sun, D. et al. Body Mass Index Drives Changes in DNA Methylation: A Longitudinal Study. Circ Res 125, 824–833 (2019).
22. Tam, B. T., Morais, J. A. & Santosa, S. Obesity and ageing: Two sides of the same coin. Obesity Reviews 21, (2020).
23. Walaszczyk, E. et al. DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA1c levels: a systematic review and replication in a case–control sample of the Lifelines study. Diabetologia 61, 354–368 (2018).
24. Ronn, T. et al. Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. Human Molecular Genetics ddv124 (2015) doi:10.1093/hmg/ddv124.
25. Willmer, T., Johnson, R., Louw, J. & Pheiffer, C. Blood-Based DNA Methylation Biomarkers for Type 2 Diabetes: Potential for Clinical Applications. Front. Endocrinol. 9, 744 (2018).
26. Ling, C. & Rönn, T. Epigenetics in Human Obesity and Type 2 Diabetes. Cell Metabolism 29, 1028–1044 (2019).
27. Cardona, A. et al. Epigenome-Wide Association Study of Incident Type 2 Diabetes in a British Population: EPIC-Norfolk Study. Diabetes 68, 2315–2326 (2019).
28. Juvinao-Quintero, D. L. et al. DNA methylation of blood cells is associated with prevalent type 2 diabetes in a meta-analysis of four European cohorts. Clin Epigenet 13, 40 (2021).
29. Ma, J. et al. A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease. Diabetes 68, 1073–1083 (2019).
30. Chambers, J. C. et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. The Lancet Diabetes & Endocrinology 3, 526–534 (2015).
31. Ahmed, S. A. H., Ansari, S. A., Mensah-Brown, E. P. K. & Emerald, B. S. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus. Clinical Epigenetics 12, 104 (2020).
32. Jhun, M.-A. et al. A multi-ethnic epigenome-wide association study of leukocyte DNA methylation and blood lipids. Nat Commun 12, 3987 (2021).
33. Muka, T. et al. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review. Nutrition, Metabolism and Cardiovascular Diseases 26, 553–566 (2016).
34. Wilson, L. E., Harlid, S., Xu, Z., Sandler, D. P. & Taylor, J. A. An epigenome-wide study of body mass index and DNA methylation in blood using participants from the Sister Study cohort. Int J Obes 41, 194–199 (2017).
35. Mendelson, M. M. et al. Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach. PLoS Med 14, e1002215 (2017).
36. Aslibekyan, S. et al. Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference: Epigenetics of Obesity. Obesity 23, 1493–1501 (2015).
37. Rohde, K. et al. Genetics and epigenetics in obesity. Metabolism 92, 37–50 (2019).
38. Campanella, G. et al. Epigenome-wide association study of adiposity and future risk of obesityrelated diseases. Int J Obes 42, 2022–2035 (2018).
39. Lupo, P. J. et al. DNA methylation and obesity in survivors of pediatric acute lymphoblastic leukemia (ALL): A report from the Childhood Cancer Survivor Study (CCSS). 1.
40. Kriebel, J. et al. Association between DNA Methylation in Whole Blood and Measures of Glucose Metabolism: KORA F4 Study. PLoS ONE 11, e0152314 (2016).
41. Arpón, A. et al. Epigenome-wide association study in peripheral white blood cells involving insulin resistance. Sci Rep 9, 2445 (2019). T
42. Mittelstraß, K. & Waldenberger, M. DNA methylation in human lipid metabolism and related diseases: Current Opinion in Lipidology 29, 116–124 (2018).
43. Pfeiffer, L. et al. DNA Methylation of Lipid-Related Genes Affects Blood Lipid Levels. Circulation. Cardiovascular genetics 8, 334–342 (2015).
44. Hedman, Å. K. et al. Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies. Circ Cardiovasc Genet 10, (2017).
45. Gomez-Alonso, M. del C. et al. DNA methylation and lipid metabolism: an EWAS of 226 metabolic measures. Clin Epigenet 13, 7 (2021).
46. Irvin, M. R. et al. Epigenome-Wide Association Study of Fasting Blood Lipids in the Genetics of Lipid Lowering Drugs and Diet Network Study. Circulation 130, 565–572 (2014).
47. Tobi, E. W. et al. DNA methylation as a mediator of the association between prenatal adversity and risk factors for metabolic disease in adulthood. Sci. Adv. 4, eaao4364 (2018).
48. Akinyemiju, T. et al. Epigenome-wide association study of metabolic syndrome in AfricanAmerican adults. Clin Epigenet 10, 49 (2018).
49. Kho, M. et al. Epigenetic loci for blood pressure are associated with hypertensive target organ damage in older African Americans from the genetic epidemiology network of Arteriopathy (GENOA) study. BMC Med Genomics 13, 131 (2020).
50. Biomarkers of Human Aging. vol. 10 (Springer International Publishing, 2019).
51. Irvin, M. R. et al. Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN study. Clin Epigenet 10, 56 (2018).
52. Sayols-Baixeras, S. et al. Identification and validation of seven new loci showing differential DNA methylation related to serum lipid profile: an epigenome-wide approach. The REGICOR study. Human Molecular Genetics 25, 4556–4565 (2016).
53. Jones, A. C., Irvin, M. R., Claas, S. A. & Arnett, D. K. Lipid Phenotypes and DNA Methylation: a Review of the Literature. Curr Atheroscler Rep 23, 71 (2021).
54. Dayeh, T. et al. DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk. Epigenetics 11, 482–488 (2016).
55. Krause, C. et al. Critical evaluation of the DNA-methylation markers ABCG1 and SREBF1 for Type 2 diabetes stratification. Epigenomics 11, 885–897 (2019).
56. Qie, R. et al. Association of ABCG1 gene methylation and its dynamic change status with incident type 2 diabetes mellitus: the Rural Chinese Cohort Study. J Hum Genet 66, 347–357 (2021).
57. Richard, M. A. et al. DNA Methylation Analysis Identifies Loci for Blood Pressure Regulation. The American Journal of Human Genetics 101, 888–902 (2017).
58. Irvin, M. R., Jones, A. C., Claas, S. A. & Arnett, D. K. DNA Methylation and Blood Pressure Phenotypes: A Review of the Literature. American Journal of Hypertension 34, 267–273 (2021).
59. Das, M. et al. Association of DNA Methylation at CPT1A Locus with Metabolic Syndrome in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) Study. PLoS ONE 11, e0145789 (2016).
60. Rathore, R., Schutt, C. R. & Van Tine, B. A. PHGDH as a mechanism for resistance in metabolically-driven cancers. CDR (2020) doi:10.20517/cdr.2020.46.
61. Huang, T. et al. DNA Methylation Variants at HIF3A Locus, B-Vitamin Intake, and Long-term Weight Change: Gene-Diet Interactions in Two U.S. Cohorts. Diabetes 64, 3146–3154 (2015).
62. Main, A. M. et al. DNA methylation and gene expression of HIF3A: cross-tissue validation and associations with BMI and insulin resistance. Clinical Epigenetics 8, 89 (2016).
63. Shen, J. et al. HIF3A DNA methylation, obesity and weight gain, and breast cancer risk among Mexican American women. Obesity Research & Clinical Practice 14, 548–553 (2020).
64. Wang, Y. et al. High Glucose Induces Lipid Accumulation via 25-Hydroxycholesterol DNA-CpG Methylation. iScience 23, 101102 (2020).
65. Ali, O. et al. Methylation of SOCS3 is inversely associated with metabolic syndrome in an epigenome-wide association study of obesity. Epigenetics 11, 699–707 (2016).
66. Wang, L. et al. Combined effects of progesterone and SOCS3 DNA methylation on T2DM: a case–control study. Clin Epigenet 13, 181 (2021).
67. , Zhang, X., Wang, Z., Hu, Y. & Sinha, R. Epigenome-wide association analysis revealed that SOCS3 methylation influences the effect of cumulative stress on obesity. Biological Psychology 131, 63–71 (2018).
68. Gao, Xu et al. Comparative validation of an epigenetic mortality risk score with three aging biomarkers for predicting mortality risks among older adult males. International Journal of Epidemiology. 48, 6, 1958-1971. (2019).
69. Zaghlool, S. B. et al. Deep molecular phenotypes link complex disorders and physiological insult to CpG methylation. Human Molecular Genetics 27, 1106–1121 (2018).
70. Kankaanpää, A. et al. Leisure-Time and Occupational Physical Activity Associates Differently with Epigenetic Aging. Medicine & Science in Sports & Exercise 53, 487–495 (2021).
71. Zannas, A. S. et al. Lifetime stress accelerates epigenetic aging in an urban, African American cohort: relevance of glucocorticoid signaling. Genome Biol 16, 266 (2015).
72. Hughes, A. et al. Socioeconomic Position and DNA Methylation Age Acceleration Across the Life Course. American Journal of Epidemiology 187, 2346–2354 (2018).
73. White, A. J., Kresovich, J. K., Xu, Z., Sandler, D. P. & Taylor, J. A. Shift work, DNA methylation and epigenetic age. International Journal of Epidemiology 48, 1536–1544 (2019).
74. Ozbay, F. et al. social support and resilience to stress: from neurobiology to clinical practice. Psychiatry (Edgmont) 4, 35–40 (2007).
75. Ma, X. et al. The Effect of Diaphragmatic Breathing on Attention, Negative Affect and Stress in Healthy Adults. Front. Psychol. 8, 874 (2017).
76. Li, J. et al. Exposure to Polycyclic Aromatic Hydrocarbons and Accelerated DNA Methylation Aging. Environ Health Perspect 126, 067005 (2018).
77. van der Laan, L. et al. Epigenetic aging biomarkers and occupational exposure to benzene, trichloroethylene and formaldehyde. Environment International 158, 106871 (2022).
78. Rider, C. F. & Carlsten, C. Air pollution and DNA methylation: effects of exposure in humans. Clinical Epigenetics 11, 131 (2019).
79. Rebelo-Marques, A. et al. Aging Hallmarks: The Benefits of Physical Exercise. Front. Endocrinol. 9, 258 (2018).
80. Spólnicka, M. et al. Modified aging of elite athletes revealed by analysis of epigenetic age markers. Aging 10, 241–252 (2018).
81. Rosen, A. D. et al. DNA methylation age is accelerated in alcohol dependence. Transl Psychiatry 8, 182 (2018).
82. Karabegović, I. et al. Epigenome-wide association meta-analysis of DNA methylation with coffee and tea consumption. Nat Commun 12, 2830 (2021).
83. Gallardo-Escribano, C. et al. Epigenetic approach in obesity: DNA methylation in a prepubertal population which underwent a lifestyle modification. Clin Epigenet 12, 144 (2020).
84. Jacka, F. N. et al. A randomised controlled trial of dietary improvement for adults with major depression (the ‘SMILES’ trial). BMC Med 15, 23 (2017).
85. American Diabetes Association. 5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2020. Diabetes Care 43, S48–S65 (2020).
86. Quach, A. et al. Epigenetic clock analysis of diet, exercise, education, and lifestyle factors. Aging 9, 419–446 (2017).
87. Lillycrop, K. A., Hoile, S. P., Grenfell, L. & Burdge, G. C. DNA methylation, ageing and the influence of early life nutrition. Proc. Nutr. Soc. 73, 413–421 (2014).
88. Nakagawa, S., Lagisz, M., Hector, K. L. & Spencer, H. G. Comparative and meta-analytic insights into life extension via dietary restriction: Dietary restriction and longevity: meta-analysis. Aging Cell 11, 401–409 (2012).
89. Colman, R. J. et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science (New York, N.Y.) 325, 201–204 (2009).
90. Hahn, O. et al. Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism. Genome Biol 18, 56 (2017).
91. Simons, M. J. P., Koch, W. & Verhulst, S. Dietary restriction of rodents decreases aging rate without affecting initial mortality rate – a meta-analysis. Aging Cell 12, 410–414 (2013).
92. Yaskolka Meir, A. et al. Lifestyle weight-loss intervention may attenuate methylation aging: the CENTRAL MRI randomized controlled trial. Clin Epigenet 13, 48 (2021).
93. Petersen, C. L., Christensen, B. C. & Batsis, J. A. Weight management intervention identifies association of decreased DNA methylation age with improved functional age measures in older adults with obesity. Clin Epigenet 13, 46 (2021).
94. Ma, J. et al. Whole Blood DNA Methylation Signatures of Diet Are Associated With Cardiovascular Disease Risk Factors and All-Cause Mortality. Circ: Genomic and Precision Medicine 13, (2020).
95. Sofi, F., Abbate, R., Gensini, G. F. & Casini, A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. The American Journal of Clinical Nutrition 92, 1189–1196 (2010).
96. Belsky, Daniel W et al. “Change in the Rate of Biological Aging in Response to Caloric Restriction: CALERIE Biobank Analysis.” The journals of gerontology. Series A, Biological sciences and medical sciences vol. 73,1 (2017): 4-10. doi:10.1093/gerona/glx096
97. Liu, C.-C., Liu, C.-C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nature Reviews. Neurology 9, 106–118 (2013).
98. Walker, R. M. et al. Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles. Genome Med 13, 1 (2021).
99. Dean, L. Methylenetetrahydrofolate Reductase Deficiency. in Medical Genetics Summaries (eds. Pratt, V. M. et al.) (National Center for Biotechnology Information (US), 2012). 98. CDC. MTHFR Gene and Folic Acid. Centers for Disease Control and Prevention (2020)
100. Van der Put, N. M. et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? American Journal of Human Genetics 62, 1044–1051 (1998).